Educational Objectives

 The role of prescription omega-3 fatty acids in the
 management of dyslipidemia.

 The role of prescription omega-3 fatty acids in the management
 of risk for coronary heart disease.

 The safety and efficacy of prescription omega-3 fatty acids including
 potential drug interactions.

 The role of the initiation of combination therapy with prescription
 omega-3 fatty acids and a statin in patients with complex lipid
 abnormalities and/or high risk for CHD.

Subject Content

 Dietary omega-3 fatty acid intake and cardiovascular risk.

 Plasma omega-6/omega-3 ratio and the risk for coronary heart disease.

 Management of dyslipidemia with prescription omega-3 fatty acid
 capsules.

 Combination therapy with statins and prescription omega-3 fatty
 acid capsules.

 Anti-atherosclerotic and anti-thrombotic effects of prescription
 omega-3 fatty acids.

 Secondary prevention of coronary heart disease with prescription
 omega-3 fatty acids.

 Clinical overview of prescription omega-3 fatty acids
 for hypertriglyceridemia.

 Coming soon! An interactive version of CLM-SAP Edition 7
 will be available through the American Diabetes Association.

Back to Complex Lipid Management